Team

Anil Agrawal – Chief Operating Officer | Ind-Swift Ltd.

Bachelor of Pharmacy – Devi Ahilya Vishva Vidyalaya, Indore, MP (1992)

Anil Agrawal is a distinguished pharmaceutical operations leader with over 32 years of industry experience. As the Chief Operating Officer of Ind-Swift Ltd., he has led large-scale pharmaceutical manufacturing and expansion projects across India and internationally, including Brazil and Japan.

He holds deep technical and operational expertise in the development, manufacturing, and regulatory compliance of a wide range of pharmaceutical dosage forms:

Dosage Forms Expertise

• Oral Solid Dosages: Tablets, Capsules, Soft Gelatin Capsules, Powders, Dry Syrups

• Parenterals: Ampoules, Vials (Liquid, Dry, Lyophilized), Prefilled Syringes, Pens, Devices, IV Bags, FFS, Vaccines & Biologicals

• Liquid Orals: Syrups and Suspensions

• Ophthalmics

• Topical Formulations: Creams, Gels, Ointments, Transdermal Patches, Lotions, Bandages, Suppositories

• Inhalers: CFC-based Aerosols, HFA-based Aerosols, Nasal Powders, Nasal Solutions, Nebulizers

Leadership in Global Operations

Anil has successfully led multi-geography teams managing multiple manufacturing sites in India and overseas. He has overseen technology transfers between facilities and driven greenfield and brownfield pharmaceutical projects, ensuring adherence to the stringent regulatory norms required to cater to highly regulated markets.

His leadership has enabled capacity expansions by more than eleven-fold over the initial installed capacities, including complete handling of new plant setup, upgrades, and renovations of existing facilities for Oral Solid Dosage (OSD) and Injectable products.

Regulatory and Compliance Excellence

He has led and successfully cleared numerous regulatory inspections and audits by authorities including:

• US FDA

• MHRA (UK)

• ANVISA (Brazil)

• TGA (Australia)

• MCC (South Africa)

• EUGMP (Europe)

• ANSM (France)

He also played a pivotal role in the remediation and resolution of US FDA Warning Letters and Consent Decrees, ensuring full compliance and continued market access.

Operational Strategy & Performance

Anil has consistently delivered on operational excellence initiatives, driving:

• Cost optimization

• Productivity improvements

• Simplified processes

• Year-on-year savings

• Targeted expansion projects within approved budgets

His operational leadership ensures On Time In Full (OTIF) delivery of products, supporting timely product launches, and maintaining strict quality standards.

Collaboration Across Functions

• Successfully partnered with R&D to meet filing targets and enable new product launches

• Collaborated with HR to build and enhance team capabilities, focusing on employee engagement, morale, and skill development

• Led MSTG (Manufacturing Science and Technology Group) to address post-commercialization issues, support R&D in technology transfers, and streamline manufacturing transitions.